{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:18:42Z","timestamp":1788002322337,"version":"build-2784847793"},"reference-count":37,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T00:00:00Z","timestamp":1787961600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Biol Rep"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1007\/s11033-026-12682-1","type":"journal-article","created":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:06:41Z","timestamp":1788001601000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of EBV EBNA1 C-terminal variations with severity of Invasive ductal carcinoma"],"prefix":"10.1007","volume":"53","author":[{"given":"Ayesha","family":"Khattak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaullah","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatima","family":"Nauman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ijaz","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,8,29]]},"reference":[{"key":"12682_CR1","doi-asserted-by":"publisher","first-page":"103835","DOI":"10.1016\/j.breast.2024.103835","volume":"79","author":"M Fu","year":"2025","unstructured":"Fu M, Peng Z, Wu M, Lv D, Li Y, Lyu S (2025) Current and future burden of breast cancer in Asia: A GLOBOCAN data analysis for 2022 and 2050. Breast 79:103835","journal-title":"Breast"},{"key":"12682_CR2","doi-asserted-by":"crossref","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, Fidler-Benaoudia MM (2025) Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. ; 1\u20139","DOI":"10.1038\/s41591-025-03502-3"},{"key":"12682_CR3","unstructured":"Global cancer observatory (2022) https:\/\/gco.iarc.who.int\/media\/globocan\/factsheets\/populations\/586-pakistan-fact-sheet.pdf (accessed on 21\/04\/2024)"},{"key":"12682_CR4","doi-asserted-by":"publisher","first-page":"43","DOI":"10.3390\/cells14010043","volume":"14","author":"LS Sadu Murari","year":"2025","unstructured":"Sadu Murari LS, Kunkel S, Shetty A, Bents A, Bhandary A, Rivera-Mulia JC (2025) p63: A Master Regulator at the Crossroads Between Development, Senescence, Aging, and Cancer. Cells 14:43","journal-title":"Cells"},{"key":"12682_CR5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.9756\/INT-JECSE\/V14I1.221085","volume":"14","author":"D Kumar","year":"2022","unstructured":"Kumar D, Tiwari N, Katoch N, Kakran N, Chatterjee A, Kumari N (2022) Breast Cancer Causes and Symptoms-A Review. INT-JECSE 14:1308\u20135581","journal-title":"INT-JECSE"},{"key":"12682_CR6","doi-asserted-by":"publisher","first-page":"641","DOI":"10.31557\/APJCP.2022.23.2.641","volume":"23","author":"M Mashaly","year":"2022","unstructured":"Mashaly M, Ghorab D, Hegazy M, Abdelkhalek M, Gaballa K, Elzehery R (2022) Association between Epstein-Bar Virus Gene Polymorphism and Breast Cancer Risk among Egyptian Females. Asian Pac J Cancer Prev 23:641\u2013650","journal-title":"Asian Pac J Cancer Prev"},{"key":"12682_CR7","doi-asserted-by":"publisher","first-page":"687","DOI":"10.31557\/APJCP.2019.20.3.687","volume":"20","author":"C Sharifpour","year":"2019","unstructured":"Sharifpour C, Makvandi M, Samarbafzadeh A, Talaei-Zadeh A, Ranjbari N, Nisi N, Azaran A, Jalilian S, Varnaseri M, Pirmoradi R, Angali KA (2019) Frequency of Epstein\u2013Barr Virus DNA in Formalin-Fixed Paraffin-Embedded 16 Tissue of Patients with Ductal Breast Carcinoma. Asian Pac J Cancer Prev 20:687\u2013692","journal-title":"Asian Pac J Cancer Prev"},{"key":"12682_CR8","doi-asserted-by":"publisher","first-page":"107226","DOI":"10.1016\/j.jbc.2024.107226","volume":"300","author":"X Zhang","year":"2024","unstructured":"Zhang X, Li Z, Peng Q, Liu C, Wu Y, Wen Y, Zheng R, Xu C, Tian J, Zheng X, Yan Q (2024) Epstein-Barr virus suppresses N6-methyladenosine modification of TLR9 to promote immune evasion. J Biol Chem 300:107226","journal-title":"J Biol Chem"},{"key":"12682_CR9","doi-asserted-by":"publisher","first-page":"e70883","DOI":"10.1002\/jmv.70883","volume":"98","author":"X Lin","year":"2026","unstructured":"Lin X, Liang J, Zhang Q, Huang Q, Zhang X, Xu M (2026) EBV Genome Variations and Association with Diseases. J Med Virol 98:e70883","journal-title":"J Med Virol"},{"key":"12682_CR10","doi-asserted-by":"publisher","first-page":"e0140529","DOI":"10.1371\/journal.pone.0140529","volume":"10","author":"L Sun","year":"2015","unstructured":"Sun L, Zhao Z, Liu S, Liu X, Sun Z, Luo B (2015) Sequence variation analysis of Epstein-Barr virus nuclear antigen 1 gene in the virus associated lymphomas of Northern China. PLoS ONE 10:e0140529","journal-title":"PLoS ONE"},{"key":"12682_CR11","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1007\/s00430-018-0561-2","volume":"208","author":"AV Banko","year":"2019","unstructured":"Banko AV, Lazarevic IB, Karalic DZ, Djukic VB, Cupic MD, Stevanovic G, Jovanovic TP (2019) The sequence analysis of Epstein\u2013Barr virus EBNA1 gene: could viral screening markers for nasopharyngeal carcinoma be identified? Med Microbiol Immunol 208:81\u201388","journal-title":"Med Microbiol Immunol"},{"key":"12682_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00705-023-05933-0","volume":"169","author":"Z Vafapour","year":"2024","unstructured":"Vafapour Z, Tabatabaie FH, Hosseini SY, Haghighat S, Hashemi SMA, Moattari A, Sarvari J (2024) Sequence variation of the Epstein-Barr virus nuclear antigen 1 (EBNA1) gene in chronic lymphocytic leukemia and healthy volunteer subjects. Arch Virol 169:1","journal-title":"Arch Virol"},{"key":"12682_CR13","doi-asserted-by":"publisher","first-page":"24","DOI":"10.30699\/ijp.2023.551761.2872","volume":"18","author":"FH Tabatabaie","year":"2023","unstructured":"Tabatabaie FH, Hosseini SY, Hashemi SMA, Safaie A, Sarvari J (2023) A preliminary sequence analysis of the Epstein-Barr virus nuclear antigen 1 (EBNA1) carboxy-terminal region in cervical and ovarian cancers. Iran J Pathol 18:24","journal-title":"Iran J Pathol"},{"key":"12682_CR14","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1038\/s41392-020-00376-4","volume":"6","author":"Y Cao","year":"2021","unstructured":"Cao Y, Xie L, Shi F, Tang M, Li Y, Hu J, Zhao L, Zhao L, Yu X, Luo X, Liao W (2021) Targeting the signaling in Epstein\u2013Barr virus-associated diseases: Mechanism, regulation, and clinical study. Signal Transduct Target Ther 6:15","journal-title":"Signal Transduct Target Ther"},{"key":"12682_CR15","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.12688\/f1000research.19422.1","volume":"8","author":"ES Ahmed","year":"2019","unstructured":"Ahmed ES, Elnour LS, Siddig EE, Hassan R (2019) Molecular detection of Epstein-Barr virus in breast cancer among Sudanese female population: a case-control study. F1000Research 8:1355","journal-title":"F1000Research"},{"key":"12682_CR16","first-page":"117822342097638","volume":"14","author":"M Al Hamad","year":"2020","unstructured":"Al Hamad M, Matalka I, Al Zoubi MS, Armogida I, Khasawneh R, Al-Husaini M, Sughayer M, Jaradat S, Al-Nasser AD, Mazzanti CM (2020) Human mammary tumor virus, human papilloma virus, and Epstein-Barr virus infection are associated with sporadic breast cancer metastasis. Breast Cancer: Basic Clin Res 14:1178223420976388","journal-title":"Breast Cancer: Basic Clin Res"},{"key":"12682_CR17","doi-asserted-by":"publisher","first-page":"211","DOI":"10.3389\/fonc.2018.00211","volume":"8","author":"MK Smatti","year":"2018","unstructured":"Smatti MK, Al-Sadeq DW, Ali NH, Pintus G, Abou-Saleh H, Nasrallah GK (2018) Epstein\u2013Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. Front Oncol 8:211","journal-title":"Front Oncol"},{"key":"12682_CR18","doi-asserted-by":"publisher","first-page":"109","DOI":"10.3390\/cancers10040109","volume":"10","author":"JB Wilson","year":"2018","unstructured":"Wilson JB, Manet E, Gruffat H, Busson P, Blondel M, Fahraeus R (2018) EBNA1: oncogenic activity, immune evasion and biochemical functions provide targets for novel therapeutic strategies against Epstein-Barr virus-associated cancers. Cancers 10:109","journal-title":"Cancers"},{"key":"12682_CR19","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1111\/j.1600-0404.2010.01410.x","volume":"124","author":"KC Simon","year":"2011","unstructured":"Simon KC, Yang X, Munger KL, Ascherio A (2011) EBNA1 and LMP1 variants in multiple sclerosis cases and controls. Acta Neurol Scand 124:53\u201358","journal-title":"Acta Neurol Scand"},{"key":"12682_CR20","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1016\/j.virusres.2011.06.011","volume":"160","author":"J-n Chen","year":"2012","unstructured":"Chen J-n, Jiang Y, Li H-g, Ding Y-g, Fan X-j, Xiao L et al (2012) Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, Southern China, An endemic area of nasopharyngeal carcinoma. Virus Res 160:191\u2013199","journal-title":"Virus Res"},{"key":"12682_CR21","doi-asserted-by":"publisher","first-page":"e13504","DOI":"10.1111\/ctr.13504","volume":"33","author":"K Sullivan","year":"2019","unstructured":"Sullivan K, Isabel S, Khodai-Booran N, Paton TA, Abdulnoor M, Dipchand AI (2019) Allen UD. Epstein\u2010Barr virus latent gene EBNA\u20101 genetic diversity among transplant patients compared with patients with infectious mononucleosis. Clin Transplant 33:e13504","journal-title":"Clin Transplant"},{"key":"12682_CR22","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.canlet.2004.01.035","volume":"211","author":"XS Zhang","year":"2004","unstructured":"Zhang XS, Wang HH, Hu LF, Li A, Zhang RH, Mai HQ, Zeng YX (2004) V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma. Cancer Lett 211:11\u201318","journal-title":"Cancer Lett"},{"key":"12682_CR23","doi-asserted-by":"publisher","first-page":"e02243","DOI":"10.1128\/mBio.02243-21","volume":"12","author":"D Westhoff Smith","year":"2021","unstructured":"Westhoff Smith D, Chakravorty A, Hayes M, Hammerschmidt W, Sugden B (2021) The epstein-barr virus oncogene EBNA1 suppresses natural killer cell responses and apoptosis early after infection of peripheral B cells. MBio 12:e02243\u2013e02221","journal-title":"MBio"},{"key":"12682_CR24","doi-asserted-by":"publisher","first-page":"34","DOI":"10.52547\/ibj.3784","volume":"27","author":"SMA Hashemi","year":"2023","unstructured":"Hashemi SMA, Moradi A, Hosseini SY, Razavi Nikoo H, Bamdad T, Faghih Z, Sarvari J, Tabarraei AA (2023) New Insight Into p53-Inhibiting Genes in Epstein\u2013Barr Virus-Associated Gastric Adenocarcinoma. Iran Biomed J 27:34\u201345","journal-title":"Iran Biomed J"},{"key":"12682_CR25","doi-asserted-by":"publisher","first-page":"8160","DOI":"10.3390\/ijms25158160","volume":"25","author":"Y Zhao","year":"2024","unstructured":"Zhao Y, Zhang Q, Zhang B, Dai Y, Gao Y, Li C, Li C (2024) Epstein\u2013Barr viruses: their immune evasion strategies and implications for autoimmune diseases. Int J Mol Sci 25:8160","journal-title":"Int J Mol Sci"},{"key":"12682_CR26","doi-asserted-by":"crossref","unstructured":"Zhang L, Ding S, Chen D, Cai B (2026) & Mu Z. T cell fate regulation in EBV-associated nasopharyngeal carcinoma. Oncol Rep. : 55; 106","DOI":"10.3892\/or.2026.9111"},{"key":"12682_CR27","doi-asserted-by":"publisher","first-page":"5307","DOI":"10.7150\/thno.26823","volume":"8","author":"L Jiang","year":"2018","unstructured":"Jiang L, Xie C, Lung HL, Lo KW, Law GL, Mak NK, Wong (2018) KL. EBNA1-targeted inhibitors: Novel approaches for the treatment of Epstein-Barr virus-associated cancers. Theranostics 8:5307","journal-title":"Theranostics"},{"key":"12682_CR28","doi-asserted-by":"publisher","first-page":"734471","DOI":"10.3389\/fimmu.2021.734471","volume":"12","author":"X Cui","year":"2021","unstructured":"Cui X, Snapper CM (2021) Epstein Barr virus: development of vaccines and immune cell therapy for EBV-associated diseases. Front Immunol 12:734471","journal-title":"Front Immunol"},{"key":"12682_CR29","doi-asserted-by":"crossref","unstructured":"Liu Y, Pan Y, Ding H, He W, Chen H, Hu Z, Ke Y (2025) Identification of Epstein-Barr virus nuclear antigen 1 (EBNA1)-specific T-cell receptors: implications for immunotherapy targeting EBV-associated malignancies. Cell Immunol. ; 105002","DOI":"10.1016\/j.cellimm.2025.105002"},{"key":"12682_CR30","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1054\/bjoc.2000.1672","volume":"84","author":"F Fina","year":"2001","unstructured":"Fina F, Romain S, Ouafik L, Palmari J, Ben Ayed F, Benharkat S, Bonnier P, Spyratos F, Foekens JA, Rose C, Buisson M, Gerard H, Reymond MO, Seigneurin JM, Martin PM (2001) Frequency and genome load of Epstein\u2013Barr virus in 509 breast cancers from different geographical areas. Br J Cancer 84:783\u2013790","journal-title":"Br J Cancer"},{"key":"12682_CR31","doi-asserted-by":"publisher","first-page":"688","DOI":"10.1158\/1055-9965.688.13.5","volume":"13","author":"SL Glaser","year":"2004","unstructured":"Glaser SL, Hsu JL, Gulley ML (2004) Epstein-Barr virus and breast cancer, state of the evidence for viral carcinogenesis. Cancer Epidemiol Biomarkers Prev 13:688\u2013697","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"12682_CR32","doi-asserted-by":"publisher","first-page":"2403","DOI":"10.7150\/jca.93631","volume":"15","author":"YC Hsu","year":"2024","unstructured":"Hsu YC, Tsai MH, Wu G, Liu CL, Chang YC, Lam HB, Yang PS (2024) Role of Epstein-Barr Virus in Breast Cancer: Correlation with Clinical Outcome and Survival Analysis. J Cancer 15:2403","journal-title":"J Cancer"},{"key":"12682_CR33","first-page":"75","volume":"8","author":"DT Lao","year":"2018","unstructured":"Lao DT, Truong KP, Huyen TAL (2018) Study of Epstein-Barr virus nuclear antigen (EBNA-1) variations: V-val type preferentially exists in biopsies of nasopharyngeal carcinoma from Vietnamese patients. Iran J Pediatr Hematol Oncol 8:75\u201386","journal-title":"Iran J Pediatr Hematol Oncol"},{"key":"12682_CR34","doi-asserted-by":"crossref","unstructured":"Frappier L Ebna1. 2025. 1\u201335","DOI":"10.1007\/82_2025_299"},{"key":"12682_CR35","doi-asserted-by":"publisher","first-page":"e1008447","DOI":"10.1371\/journal.ppat.1008447","volume":"16","author":"Y Wang","year":"2020","unstructured":"Wang Y, Du S, Zhu C, Wang C, Yu N, Lin Z et al (2020) STUB1 is targeted by the SUMO interacting motif of EBNA1 to maintain Epstein-Barr Virus latency. PLoS Pathog 16:e1008447","journal-title":"PLoS Pathog"},{"key":"12682_CR36","doi-asserted-by":"publisher","first-page":"914","DOI":"10.3389\/fgene.2019.00914","volume":"10","author":"Z Zeng","year":"2019","unstructured":"Zeng Z, Bromberg Y (2019) Predicting functional effects of synonymous variants: a systematic review and perspectives. Front Genet 10:914","journal-title":"Front Genet"},{"key":"12682_CR37","doi-asserted-by":"publisher","first-page":"132","DOI":"10.3390\/biom14010132","volume":"14","author":"P Oelschlaeger","year":"2024","unstructured":"Oelschlaeger P (2024) Molecular mechanisms and the significance of synonymous mutations. Biomolecules 14:132","journal-title":"Biomolecules"}],"container-title":["Molecular Biology Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11033-026-12682-1","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11033-026-12682-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T11:06:42Z","timestamp":1788001602000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11033-026-12682-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,29]]},"references-count":37,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,12]]}},"alternative-id":["12682"],"URL":"https:\/\/doi.org\/10.1007\/s11033-026-12682-1","relation":{},"ISSN":["0301-4851","1573-4978"],"issn-type":[{"value":"0301-4851","type":"print"},{"value":"1573-4978","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,29]]},"assertion":[{"value":"17 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 August 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 August 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"All the authors declared that there is no conflict of interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1498"}}